Foley & Lardner LLP represented Hanwha Impact Partners on the deal. Hanwha Impact Partners acted as lead investor in the $121 million Series C funding round for...
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP advised BICO Group on the deal. Bio convergence company BICO Group AB (“BICO”) announced its acquisition of Allegro 3D, a San Diego-based...
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP advised AltheaDx on the deal. AltheaDx, Inc., a mental health diagnostics company, announced its recent acquisition by Castle Biosciences, Inc., a company...
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP advised Biotron Laboratories and Talus Mineral Company on the deal. Biotron Laboratories and Talus Mineral Company (collectively “Biotron”), two affiliated entities that...
You must be a Standard 1 Year member to access this content.
Foley & Lardner advised BICO Group on the deal. Boston-based bio convergence company BICO Group AB (“BICO”) announced its acquisition of Biosero, Inc. (“Biosero”), a San Diego-based...
You must be a Standard 1 Year member to access this content.
Foley & Lardner advised Hansoh Pharma on the deal. Shanghai-based research and development company Hansoh Pharmaceutical Group Co, Ltd announced its collaboration with London-based biotechnology company Silence Therapeutics...
You must be a Standard 1 Year member to access this content.
